Abeona Therapeutics - 40 Year Stock Price History | ABEO

Historical daily share price chart and data for Abeona Therapeutics since 1980 adjusted for splits. The latest closing stock price for Abeona Therapeutics as of July 01, 2020 is 2.85.
  • The all-time high Abeona Therapeutics stock closing price was 106250.00 on May 21, 1981.
  • The Abeona Therapeutics 52-week high stock price is 5.19, which is 82.1% above the current share price.
  • The Abeona Therapeutics 52-week low stock price is 1.35, which is 52.6% below the current share price.
  • The average Abeona Therapeutics stock price for the last 52 weeks is 2.79.
Abeona Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 2.7196 3.2100 4.0800 1.4500 2.8500 -12.84%
2019 4.8851 7.0300 8.3100 1.5400 3.2700 -54.20%
2018 13.8195 17.2000 21.4500 6.4000 7.1400 -54.95%
2017 9.4940 5.0000 19.9500 4.6000 15.8500 226.80%
2016 3.8948 3.4200 8.7000 2.1000 4.8500 44.35%
2015 4.6488 3.4000 9.8000 2.7700 3.3600 -2.61%
2014 15.8543 12.5000 29.5000 3.4400 3.4500 -72.40%
2013 20.4325 13.5000 30.0000 11.5000 12.5000 4.17%
2012 37.5400 70.0000 72.0000 11.0000 12.0000 -83.33%
2011 100.4960 123.5000 129.5000 66.0000 72.0000 -41.94%
2010 124.7679 160.0000 164.5000 90.0000 124.0000 -24.62%
2009 118.4524 45.0000 235.0000 38.5000 164.5000 232.32%
2008 121.3162 171.0000 175.0000 40.0000 49.5000 -69.54%
2007 229.4980 145.0000 513.0000 120.0000 162.5000 16.07%
2006 66.6733 127.5000 147.5000 5.0000 140.0000 7.69%
2005 446.4286 860.0000 870.0000 130.0000 130.0000 -85.31%
2004 1241.5575 1297.5000 1987.5000 632.5000 885.0000 -32.44%
2003 805.7639 462.5000 1375.0000 437.5000 1310.0000 249.33%
2002 667.0040 1112.5000 1412.5000 287.5000 375.0000 -66.22%
2001 933.9541 1250.0000 1562.5000 575.0000 1110.0000 -11.20%
2000 1363.6225 437.5000 3468.7500 406.2500 1250.0000 150.00%
1999 602.3392 593.7500 1015.6250 289.0750 500.0000 -11.11%
1998 1020.8502 2734.5000 3515.5000 281.2500 562.5000 -79.43%
1997 2824.0356 3906.5000 6094.0000 1015.5000 2734.5000 -27.08%
1996 7465.3228 5312.5000 13437.5000 3750.0000 3750.0000 -29.41%
1995 2601.7520 2969.0000 5625.0000 469.0000 5312.5000 88.89%
1994 4650.6389 5937.5000 8750.0000 2187.5000 2812.5000 -55.00%
1993 10565.7154 15625.0000 16875.0000 5625.0000 6250.0000 -54.55%
1992 17685.7776 15000.0000 28750.0000 11250.0000 13750.0000 -8.33%
1991 7264.0850 2500.0000 16875.0000 2500.0000 15000.0000 500.00%
1990 5326.0909 6250.0000 9375.0000 2500.0000 2500.0000 -55.56%
1989 16593.5020 13750.0000 23125.0000 4062.5000 5625.0000 -59.09%
1988 18102.7668 16875.0000 29375.0000 11875.0000 13750.0000 -12.00%
1987 34473.8142 34375.0000 51250.0000 13125.0000 15625.0000 -52.83%
1986 36534.0909 35000.0000 53750.0000 26250.0000 33125.0000 -5.36%
1985 33970.7341 28750.0000 50000.0000 25000.0000 35000.0000 19.15%
1984 24024.2095 32500.0000 38750.0000 13750.0000 29375.0000 -11.32%
1983 47954.5455 73750.0000 73750.0000 26250.0000 33125.0000 -56.56%
1982 65909.0909 75000.0000 91250.0000 50000.0000 76250.0000 3.39%
1981 77257.9051 66250.0000 106250.0000 56250.0000 73750.0000 11.32%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.244B $0.003B
Abeona Therapeutics, Inc. is engaged in developing and delivering gene therapy and plasma-based products for rare diseases. Abeona Therapeutics Inc., formerly known as PlasmaTech Biopharmaceuticals, Inc., is based in Dallas, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $138.744B 15.28
Gilead Sciences (GILD) United States $96.511B 12.51
CSL (CSLLY) Australia $90.660B 0.00
Vertex Pharmaceuticals (VRTX) United States $75.271B 51.75
Regeneron Pharmaceuticals (REGN) United States $68.613B 26.45
Illumina (ILMN) United States $54.441B 55.94
Biogen (BIIB) United States $43.661B 7.47
Seattle Genetics (SGEN) United States $29.413B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.786B 10.65
Moderna (MRNA) United States $23.836B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $23.288B 0.00
Incyte (INCY) United States $22.600B 0.00
BioMarin Pharmaceutical (BMRN) United States $22.304B 202.20
Genmab (GMAB) Denmark $22.123B 18.22
Genmab (GNMSF) Denmark $20.669B 61.36
Alnylam Pharmaceuticals (ALNY) United States $17.086B 0.00
BioNTech SE (BNTX) Germany $15.101B 0.00
BeiGene (BGNE) Cayman Islands $14.571B 0.00
Exact Sciences (EXAS) United States $13.034B 0.00
Bio-Rad Laboratories (BIO.B) United States $12.955B 58.97
Galapagos (GLPG) Belgium $12.873B 37.87
Sarepta Therapeutics (SRPT) United States $12.505B 0.00
Horizon Therapeutics Public (HZNP) Ireland $10.603B 26.09
ARGENX SE-ADR (ARGX) Netherlands $10.588B 0.00
Bio-Techne Corp (TECH) United States $10.094B 66.68
QIAGEN (QGEN) Netherlands $9.750B 28.35
Immunomedics (IMMU) United States $8.183B 0.00
Guardant Health (GH) United States $7.673B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.555B 0.00
Exelixis (EXEL) United States $7.280B 25.53
Ascendis Pharma (ASND) Denmark $7.097B 0.00
Repligen (RGEN) United States $6.466B 113.40
Adaptive Biotechnologies (ADPT) United States $6.139B 0.00
Reata Pharmaceuticals (RETA) United States $5.186B 0.00
Acceleron Pharma (XLRN) United States $5.128B 0.00
Mirati Therapeutics (MRTX) United States $4.983B 0.00
Novavax (NVAX) United States $4.831B 0.00
Vir Biotechnology (VIR) United States $4.830B 0.00
Zai Lab (ZLAB) China $4.772B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.666B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.554B 97.99
MyoKardia (MYOK) United States $4.510B 0.00
Inovio Pharmaceuticals (INO) United States $4.261B 0.00
Blueprint Medicines (BPMC) United States $4.227B 0.00
MorphoSys AG (MOR) Germany $4.167B 32.32
Emergent Biosolutions (EBS) United States $4.146B 27.17
China Biologic Products (CBPO) China $4.022B 22.36
Momenta Pharmaceuticals (MNTA) United States $3.916B 0.00
Amicus Therapeutics (FOLD) United States $3.886B 0.00
Global Blood Therapeutics (GBT) United States $3.847B 0.00
Halozyme Therapeutics (HALO) United States $3.641B 0.00
Bluebird Bio (BLUE) United States $3.397B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.336B 0.00
NeoGenomics (NEO) United States $3.263B 238.31
Arena Pharmaceuticals (ARNA) United States $3.169B 0.00
Alkermes (ALKS) Ireland $3.080B 60.64
Insmed (INSM) United States $2.783B 0.00
Amarin (AMRN) Ireland $2.668B 0.00
Fate Therapeutics (FATE) United States $2.666B 0.00
Denali Therapeutics (DNLI) United States $2.554B 0.00
Viela Bio (VIE) United States $2.209B 0.00
UniQure (QURE) Netherlands $1.997B 0.00
Principia Biopharma (PRNB) United States $1.976B 0.00
PHARMA MAR SA (PHMMF) Spain $1.936B 0.00
Alector (ALEC) United States $1.932B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.877B 0.00
Twist Bioscience (TWST) United States $1.856B 0.00
Eidos Therapeutics (EIDX) United States $1.837B 0.00
Ligand Pharmaceuticals (LGND) United States $1.795B 69.91
I-Mab (IMAB) China $1.708B 0.00
Intra-Cellular Therapies (ITCI) United States $1.706B 0.00
Adverum Biotechnologies (ADVM) United States $1.677B 0.00
Zymeworks (ZYME) Canada $1.643B 0.00
Editas Medicine (EDIT) United States $1.634B 0.00
Epizyme (EPZM) United States $1.623B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.578B 0.00
Mersana Therapeutics (MRSN) United States $1.567B 0.00
Beam Therapeutics (BEAM) United States $1.442B 0.00
Cytokineticsorporated (CYTK) United States $1.402B 0.00
Revance Therapeutics (RVNC) United States $1.393B 0.00
Zealand Pharma (ZEAL) Denmark $1.391B 0.00
Akcea Therapeutics (AKCA) United States $1.385B 0.00
REGENXBIO (RGNX) United States $1.372B 0.00
Zealand Pharma (ZLDPF) Denmark $1.369B 0.00
NGM Biopharmaceuticals (NGM) United States $1.345B 0.00
Mesoblast (MESO) Australia $1.327B 0.00
Sorrento Therapeutics (SRNE) United States $1.317B 0.00
Arvinas (ARVN) United States $1.313B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.302B 0.00
Coherus BioSciences (CHRS) United States $1.267B 8.84
Sangamo Therapeutics (SGMO) United States $1.262B 0.00
NantKwest (NK) United States $1.210B 0.00
Arcus Biosciences (RCUS) United States $1.139B 0.00
Athenex (ATNX) United States $1.123B 0.00
Intellia Therapeutics (NTLA) United States $1.080B 0.00
Compugen (CGEN) Israel $1.028B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.964B 0.00
Alcobra (ARCT) United States $0.930B 0.00
Retrophin (RTRX) United States $0.881B 0.00
Heska (HSKA) United States $0.875B 0.00
Intrexon (PGEN) United States $0.859B 0.00
Myriad Genetics (MYGN) United States $0.845B 43.62
BAVARIAN NORDIC (BVNRY) Denmark $0.834B 35.83
Morphic Holding (MORF) United States $0.828B 0.00
Kadmon Holdings (KDMN) United States $0.819B 0.00
Dynavax Technologies (DVAX) United States $0.818B 0.00
Pharming Group (PHGUF) Netherlands $0.814B 21.67
Cara Therapeutics (CARA) United States $0.800B 0.00
Cellectis S.A (CLLS) France $0.756B 0.00
Frequency Therapeutics (FREQ) United States $0.721B 0.00
VBI Vaccines (VBIV) United States $0.715B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.703B 0.00
Cue Biopharma (CUE) United States $0.697B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.679B 0.00
Codexis (CDXS) United States $0.673B 0.00
Agenus (AGEN) United States $0.658B 0.00
Castle Biosciences (CSTL) United States $0.649B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.644B 0.00
Sinovac Biotech (SVA) China $0.640B 20.87
Aquinox Pharmaceuticals (NLTX) United States $0.637B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.624B 5.35
Vericel (VCEL) United States $0.623B 115.17
Bellus Health (BLU) Canada $0.621B 0.00
AnaptysBio (ANAB) United States $0.609B 0.00
MiMedx (MDXG) United States $0.597B 0.00
NextCure (NXTC) United States $0.590B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.584B 0.00
Kala Pharmaceuticals (KALA) United States $0.574B 0.00
Cel-Sci (CVM) United States $0.562B 0.00
UROGEN PHARMA (URGN) United States $0.546B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.545B 0.00
Scholar Rock Holding (SRRK) United States $0.544B 0.00
Athersys (ATHX) United States $0.542B 0.00
Anika Therapeutics (ANIK) United States $0.536B 17.23
Syndax Pharmaceuticals (SNDX) United States $0.535B 0.00
Clovis Oncology (CLVS) United States $0.519B 0.00
Syros Pharmaceuticals (SYRS) United States $0.487B 0.00
Protagonist Therapeutics (PTGX) United States $0.485B 0.00
DBV Technologies S.A (DBVT) France $0.482B 0.00
MeiraGTx Holdings (MGTX) United States $0.468B 0.00
Merus (MRUS) Netherlands $0.467B 0.00
AC Immune SA (ACIU) Switzerland $0.455B 0.00
Geron (GERN) United States $0.443B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.439B 0.00
BioDelivery Sciences (BDSI) United States $0.437B 22.95
Precision BioSciences (DTIL) United States $0.432B 0.00
Prothena (PRTA) Ireland $0.417B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.412B 0.00
Puma Biotechnology (PBYI) United States $0.411B 0.00
Albireo Pharma (ALBO) United States $0.397B 0.00
ANI Pharmaceuticals (ANIP) United States $0.392B 7.76
CytomX Therapeutics (CTMX) United States $0.383B 0.00
MannKind (MNKD) United States $0.373B 0.00
WAVE Life Sciences (WVE) Singapore $0.372B 0.00
Avid Bioservices (CDMO) United States $0.371B 0.00
Affimed (AFMD) Germany $0.352B 0.00
OSMOTICA PHARM (OSMT) United States $0.347B 0.00
Seres Therapeutics (MCRB) United States $0.346B 0.00
Kamada (KMDA) Israel $0.345B 14.37
PDL BioPharma (PDLI) United States $0.339B 291.00
Starpharma Holdings (SPHRY) Australia $0.303B 0.00
Celldex Therapeutics (CLDX) United States $0.293B 0.00
Cellular Biomedicine (CBMG) United States $0.290B 0.00
Menlo Therapeutics (MNLO) United States $0.290B 0.00
Pfenex (PFNX) United States $0.286B 0.00
ChromaDex (CDXC) United States $0.282B 0.00
Verastem (VSTM) United States $0.280B 0.00
Spero Therapeutics (SPRO) United States $0.279B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.279B 0.00
IBio (IBIO) United States $0.263B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.262B 0.00
IVERIC Bio (ISEE) United States $0.262B 0.00
HOOKIPA Pharma (HOOK) United States $0.254B 0.00
ADMA Biologics Inc (ADMA) United States $0.253B 0.00
Prometic Life Sciences (LMNL) Canada $0.253B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.253B 0.00
Selecta Biosciences (SELB) United States $0.248B 0.00
Gritstone Oncology (GRTS) United States $0.247B 0.00
Northwest Biotherapeutics (NWBO) United States $0.247B 0.00
Liquidia Technologies (LQDA) United States $0.239B 0.00
Dyadic (DYAI) United States $0.238B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.225B 0.00
Five Prime Therapeutics (FPRX) United States $0.223B 0.00
Fortress Biotech (FBIO) United States $0.221B 0.00
Pluristem Therapeutics (PSTI) Israel $0.220B 0.00
XOMA (XOMA) United States $0.218B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.213B 3.22
Exicure (XCUR) United States $0.213B 0.00
GENFIT S.A (GNFT) France $0.208B 0.00
Strongbridge Biopharma (SBBP) United States $0.205B 0.00
POXEL SA FRANCE (PXXLF) France $0.202B 0.00
Aptinyx (APTX) United States $0.190B 0.00
Aduro Biotech (ADRO) United States $0.187B 0.00
ARAVIVE, INC (ARAV) United States $0.186B 0.00
Sutro Biopharma (STRO) United States $0.180B 0.00
Kindred Biosciences (KIN) United States $0.176B 0.00
Aytu Bioscience (AYTU) United States $0.171B 0.00
CorMedix Inc (CRMD) United States $0.165B 0.00
Cyclerion Therapeutics (CYCN) United States $0.164B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.162B 0.00
Trevena (TRVN) United States $0.161B 0.00
VolitionRX (VNRX) United States $0.160B 0.00
Cerecor (CERC) United States $0.155B 0.00
Theratechnologies (THTX) Canada $0.155B 0.00
VTv Therapeutics (VTVT) United States $0.152B 0.00
Cidara Therapeutics (CDTX) United States $0.152B 0.00
Celyad SA (CYAD) Belgium $0.149B 0.00
Biofrontera AG (BFRA) Germany $0.148B 0.00
TELA Bio (TELA) United States $0.148B 0.00
Applied Genetic Technologies (AGTC) United States $0.143B 0.00
Lumos Pharma (LUMO) United States $0.136B 0.00
Orgenesis (ORGS) United States $0.134B 0.00
PHASEBIO PHARMA (PHAS) United States $0.132B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.130B 0.00
Arbutus Biopharma (ABUS) United States $0.126B 0.00
Protalix BioTherapeutics (PLX) Israel $0.123B 0.00
AIT Therapeutics (XAIR) United States $0.122B 0.00
Celsion (CLSN) United States $0.119B 0.00
Oncobiologics (OTLK) United States $0.118B 0.00
Palatin Technologies (PTN) United States $0.117B 3.01
Catabasis Pharmaceuticals (CATB) United States $0.115B 0.00
Eton Pharmaceuticals (ETON) United States $0.114B 0.00
Checkpoint Therapeutics (CKPT) United States $0.109B 0.00
Enzo Biochem (ENZ) United States $0.107B 0.00
AquaBounty Technologies (AQB) United States $0.103B 0.00
DiaMedica Therapeutics (DMAC) United States $0.098B 0.00
Cardiff Oncology (CRDF) United States $0.096B 0.00
Windtree Therapeutics (WINT) United States $0.096B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.094B 0.00
Antibe Therapeutics (ATBPF) Canada $0.092B 0.00
Clearside Biomedical (CLSD) United States $0.084B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.083B 0.00
Emmaus Life Sciences (EMMA) United States $0.081B 0.00
Adocia (ADOCY) France $0.080B 0.00
SESEN BIO, INC (SESN) United States $0.080B 0.00
Cocrystal Pharma (COCP) United States $0.079B 0.00
Organovo Holdings (ONVO) United States $0.072B 0.00
Proteostasis Therapeutics (PTI) United States $0.071B 0.00
Catalyst Biosciences (CBIO) United States $0.071B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.070B 0.00
Happiness Biotech Group (HAPP) China $0.070B 0.00
Synlogic (SYBX) United States $0.067B 0.00
Stealth BioTherapeutics (MITO) United States $0.064B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.064B 0.00
Idera Pharmaceuticals (IDRA) United States $0.060B 0.00
Vaccinex (VCNX) United States $0.060B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.059B 0.00
Signal Genetics (MGEN) United States $0.059B 0.00
Ecology Coatings (ABVC) United States $0.058B 0.00
AnPac Bio-Medical Science (ANPC) China $0.058B 0.00
CollPlant Holdings (CLGN) Israel $0.057B 0.00
Soligenix (SNGX) United States $0.056B 0.00
Vascular Biogenics (VBLT) Israel $0.054B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.051B 0.00
Apricus Biosciences (SEEL) United States $0.045B 0.00
Curis (CRIS) United States $0.044B 0.00
Pulmatrix (PULM) United States $0.044B 0.00
Edesa Biotech (EDSA) Canada $0.044B 0.00
AmpliPhi Biosciences (ARMP) United States $0.043B 0.00
Bionano Genomics (BNGO) United States $0.043B 0.00
Prima BioMed (IMMP) Australia $0.042B 0.00
ATyr Pharma (LIFE) United States $0.042B 0.00
Cesca Therapeutics (THMO) United States $0.035B 0.00
Acorda Therapeutics (ACOR) United States $0.035B 0.00
Chanticleer Holdings (SONN) United States $0.033B 0.00
OvaScience (MLND) United States $0.033B 0.00
Advaxis (ADXS) United States $0.033B 0.00
Alimera Sciences (ALIM) United States $0.032B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.029B 0.00
Cleveland BioLabs (CBLI) United States $0.029B 0.00
Titan Pharmaceuticals (TTNP) United States $0.029B 0.00
Spherix (AIKI) United States $0.029B 0.00
Aptevo Therapeutics (APVO) United States $0.027B 0.00
IMMURON (IMRN) Australia $0.027B 0.00
BioPharmX (TMBR) United States $0.026B 0.00
Evogene (EVGN) Israel $0.026B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.025B 0.00
Novogen (KZIA) Australia $0.024B 0.00
FORTE BIOSCIENC (FBRX) United States $0.023B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.023B 0.00
Entera Bio (ENTX) Israel $0.021B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
Prana Biotechnology (ATHE) Australia $0.017B 0.00
BioCardia (BCDA) United States $0.016B 0.00
VIVUS (VVUS) United States $0.015B 0.00
Unum Therapeutics (UMRX) United States $0.014B 0.00
Neuralstem (SNCA) United States $0.012B 0.00
TRACON Pharmaceuticals (TCON) United States $0.011B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00